Sort
48,018 grants matching “immunotherapy”
Improving the platelet-mediated immune checkpoint inhibitor delivery for treating triple-negative breast cancer
$619,764Quanyin Hu · University Of Wisconsin-Madison · R01 · FY2025 · CA
Development of new passive immunization strategies for anthrax
$619,753Arturo Casadevall · Columbia University Health Sciences · U54 · FY2010 · AI
Intravenous VSV virotherapy in lymphoma
$619,753Kah-Whye Peng · Mayo Clinic Rochester · R01 · FY2025 · CA
Intravenous VSV virotherapy in lymphoma
$619,753Kah-Whye Peng · Mayo Clinic Rochester · R01 · FY2023 · CA
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease
$619,744Todd Jonathan Cohen · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AG
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease
$619,744Todd Jonathan Cohen · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AG
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease
$619,744Todd Jonathan Cohen · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AG
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease
$619,744Todd Jonathan Cohen · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AG
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease
$619,744Todd Jonathan Cohen · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AG
Therapeutic Vaccine for HIV/HPV-associated Oropharyngeal and Tonsillar Malignanci
$619,720Frank R. Jones · Etubics Corporation · R44 · FY2013 · DE
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$619,714Jin Wang · Baylor College Of Medicine · R01 · FY2023 · CA
Targeting B7-H3 in ovarian cancer
$619,664Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Development and validation of an autologous mouse model for the study of immune interactions with glioblastoma
$619,628Zev Ari Binder · University Of Pennsylvania · R37 · FY2024 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$619,610Gerald V Denis · Boston University Medical Campus · R01 · FY2021 · CA
Cancer Chemotherapy Training Program
$619,504Sloan-Kettering Institute For Cancer Res · T32 · FY2003 · CA
Neoadjuvant immunoradiotherapy for HPV mediated oropharynx cancer
$619,487Joseph A Califano · University Of California, San Diego · R01 · FY2025 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$619,470Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
IL-2R-dependent mechanisms in regulation of Treg homeostasis and autoimmunity
$619,414Thomas R Malek · University Of Miami School Of Medicine · R01 · FY2024 · AI
IL-2R-dependent mechanisms in regulation of Treg homeostasis and autoimmunity
$619,414Thomas R Malek · University Of Miami School Of Medicine · R01 · FY2020 · AI
IL-2R-dependent mechanisms in regulation of Treg homeostasis and autoimmunity
$619,414Thomas R Malek · University Of Miami School Of Medicine · R01 · FY2021 · AI
IL-2R-dependent mechanisms in regulation of Treg homeostasis and autoimmunity
$619,414Thomas R Malek · University Of Miami School Of Medicine · R01 · FY2023 · AI
Linking insertional mutagenesis and cell function to improve CAR T cell therapy
$619,360Frederic D Bushman · University Of Pennsylvania · R01 · FY2020 · CA
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection
$619,311M. Javad Aman · Abvacc, Inc. · R01 · FY2024 · AI
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab
$619,306Edith A Perez · Mayo Clinic Jacksonville · R01 · FY2011 · CA
CPMV-Polymer Devices to Enhance the Outcomes of Intratumoral Immunotherapy
$619,294Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2024 · CA